David Malka retweeted
$39,800 USD. Per month.
The @nytimes puts a spotlight on the extraordinary cost of daraxonrasib—a major advance in pancreatic cancer.
We should celebrate this amazing scientific breakthrough - but should still question this exorbitant pricing benchmark and the profound access challenges this creates for pts in the US and globally …and cannot become the ‘new normal’.
There is no impact of #innovation without #access 🇨🇦 🇺🇸🌎
nytimes.com/2026/08/31/busin…
@OncoAlert
@cancersociety
@PanCAN
@CraigsCauseCan
David Malka retweeted
Invade a country.
Call those helping it defend itself "warmongers".
Blame reversal as a lifestyle.
David Malka retweeted
🚨 This may be the most consequential oncology study of 2026.
Yes, on par with daraxonrasib.
At #ASCO26 we highlighted the 5-year KEYNOTE-942 data for the individualized mRNA cancer vaccine intismeran + pembrolizumab in resected high-risk melanoma.
And the numbers were 👀
RFS HR 0.51
5-year RFS: 68.8% vs 49.1%
DMFS HR 0.41
OS HR 0.47 (still immature)
Amazing data. But 157 patients. Phase IIb.
The big question: does it hold up in phase III?
Apparently, yes. 🔥
INTerpath-001 randomized 1,137 patients with resected stage IIB-IV melanoma to intismeran + pembrolizumab vs pembrolizumab alone.
At the prespecified interim analysis:
✅ RFS met
✅ DMFS met
✅ Statistically significant AND
✅ No new safety signals
We don’t have the HRs yet. So some restraint until we see the actual data (also this is a press release, so grain of salt)
But why is this such a big deal?
Because this isn’t really about melanoma.
🧬 Sequence YOUR tumor
🎯 Identify YOUR neoantigens
💉 Manufacture a vaccine specifically for YOUR cancer
🦠 Train YOUR immune system to recognize it
And now that approach has succeeded in a randomized phase III trial.
This is actually personalized.
And if this platform works across tumor types, the implications are enormous.
Daraxonrasib may change how we treat RAS-driven cancers.
INTerpath-001 may change how we think about cancer vaccines altogether.
2026 has been an amazing year for oncology advances. 🔥
merck.com/news/merck-and-mod…
@OncoAlert @Onco_Nexus @TheGutOncLab
David Malka retweeted
Canicule – Le ministère de la Santé conseille de ne pas sortir entre midi et octobre
pour toi @Procto_Log
David Malka retweeted
En l'honneur de Chuck Norris, une minute de bagarre observée à l'Assemblée nationale legorafi.fr/2026/03/20/en-lh…
David Malka retweeted
With updated goggles — and a calendar set to 2026 rather than a 2024 press clipping — the picture becomes clearer:
🛳️ Aircraft carrier Charles de Gaulle leading its strike group
🚢 8 frigates
🚁 2 amphibious helicopter carriers
✈️ Rafale jets supporting regional partners
France 🇫🇷 — not so invisible for those willing to look.
So, the French government decided it would be a good idea to send a frigate to the Red Sea as a deterrent against the Houthis, but then decided to withdraw due to the deterrence of the Houthis....
😂😂😂
thecradle.co/articles-id/243…
Readers added context they thought people might want to know
This article is 2 years old and doesn’t reflect today’s reality.
France sent dozens of warships according to Reuters
reuters.com/world/europe/f…
David Malka retweeted
✖️No U.S. assets deployed on French bases in the Middle East.
✔️Yes: U.S. assets accepted on Istres Airbase (France) as part of a routine NATO procedure. They are not involved in U.S. operations in Iran but strictly supporting the defense of our partners in the region.
This quoted post is unavailable.
David Malka retweeted
If protecting allies counts as “joining a war,” definitions may need revisiting.
BREAKING:
France and Germany join the US war on Iran
Readers added context they thought people might want to know
France & Germany are only carrying out defensive actions (shooting down drones & missiles) in allied countries airspace hit by Iran (Cyprus, UAE).
They haven't joined the US-Israel offensive & condemned it on multiple occasions.
elysee.fr/en/emmanuel-ma…
David Malka retweeted
« Strong partners » indeed.
Rather than « well funded customers ».
The United States opposes any efforts to incorporate European preference in the EU Defense Procurement Directive. We fully support European rearmament and a revitalization of the European defense industrial base. However, European preference in the Directive would undermine member state flexibility to make national procurement purchases, hinder European rearmament efforts, create barriers for Allies reaching NATO capability targets, and run counter to European commitments in the 2025 U.S.-EU Joint Statement on trade and Reciprocal Defense Procurement Agreements.
Our full statement here:
ec.europa.eu/info/law/better…
Readers added context they thought people might want to know
US laws like Buy American Act & Berry Amendment mandate domestic preferences in defense, similar to opposed EU proposal. Post accurately states US opposition per feedback; harm claims are opinions. congress.gov/crs-product/IF… acq.osd.mil/asda/dpc/cp/ic… ec.europa.eu/info/law/bette…
David Malka retweeted
🇺🇸 US: 6,7 homicides per 100k inhabitants
🇫🇷 France: 1,5 homicides per 100k inhabitants
We will continue to watch this case.
Democracy rests on a basic bargain: you get to bring any viewpoint to the public square, and nobody gets to kill you for it.
This is why we treat political violence — terrorism — so harshly. Once you decide to kill people for their opinions instead of persuade them, you’ve opted out of civilization.
We will continue to watch this case.
David Malka retweeted
Visitors running away.
.@POTUS on Europe: “They’ve got a big problem on their hands. Between immigration and energy, Europe is destroying itself – and they better get smart … it’s not recognizable, Europe, if you go through the different cities. It’s a very sad thing.”
Readers added context they thought people might want to know
A small correction: in 2025, France was also the world's leading tourist destination with approximately 103 million entries, ahead of Spain.
partir.ouest-france.fr/magazine/plus-…
rmc.bfmtv.com/actualites/eco….
David Malka retweeted
76 % des Français favorables à la création de wagons SNCF sans cadres sup en conf’ call legorafi.fr/2026/01/29/76-de…





























